FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for Clarithromycin from Sandoz Inc, marking regulatory clearance for changes to this generic antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Sinusitis
• Community-acquired Pneumonia
• Helicobacter Pylori Infection
• Otitis Media
• Pharyngitis
• Skin and Soft Tissue Infections
• Tonsillitis

Drugs mentioned

• clarithromycin (clarithromycin)

Snippet

SUPPL AP for CLARITHROMYCIN (CLARITHROMYCIN)